Diatech Pharmacogenetics is pleased to announce its new Continuing Medical Education project “Carcinoma Uroteliale Metastatico 2.0. Nuove prospettive terapeutiche della medicina di precisione”, co-sponsored with Johnson&Johnson
Don’ t miss it on December 15 at 3.00 PM.